News & Articles

Laboratory expands access to innovative solutions for safer pregnancies and healthier babies in India

Novel strategy shortens time to heart attack diagnosis drastically, enabling faster start of treatment of patients and better use of healthcare resources

Lonza and Renova Therapeutics Announce Manufacturing Agreement for Clinical Supply of RT-100 Gene Therapy

Multi-phase collaboration to advance next-generation sequencing, single-cell biology, and bioinformatics Sample to Insight solutions

Roche Presents Updated Results for Investigational Cancer Immunotherapy Atezolizumab in Advanced Bladder Cancer

Hear from the winner of the Best New Drug Discovery Product of 2015, Thermo Fisher Scientific

Agena Bioscience Partners with DaRui Biotech to Bring MassARRAY Technology to the Diagnostics Market in China

Discover the winning product, voted for by scientists worldwide

Third offering in Quest's precision medicine menu for oncology immunotherapies

Key role for oxidative stress

Are amyloid plaques the best therapeutic target?

The ideal solution for scaling studies and low volume ultra- and diafiltration operations

Which product made the most difference to drug discovery research in 2015?

World first human trial aims to treat resistant head and neck cancer

New regional BioPharma Services hub offers larger operational space and advanced equipment to meet increasing clinical supply needs for pharma and biotech customers

Greg Caruso discusses the installation of a new chemistry system and laboratory water supply

Which new product made the most difference to your laboratory in 2015?

Universal test designed for non-small cell lung cancer supports multiple drug development programs

Offering scientists an opportunity for face-to-face meetings to discuss strategies for accelerating biosimilar development

Dr Emilio Diez-Monedero explains the current approach to molecular drug discovery and gives SelectScience a sneak peek into the SLAS Spanish Drug Discovery Network Meeting

A first-in-man clinical study is planned to start in 2016, with top line results expected end 2017

AMSBIO has introduced an expanded range of Adeno-associated virus (AAV) cloning and packaging services